PMID- 21695550 OWN - NLM STAT- MEDLINE DCOM- 20111123 LR - 20211020 IS - 1432-1211 (Electronic) IS - 0093-7711 (Print) IS - 0093-7711 (Linking) VI - 63 IP - 11 DP - 2011 Nov TI - HLA class I allele promiscuity revisited. PG - 691-701 LID - 10.1007/s00251-011-0552-6 [doi] AB - The peptide repertoire presented on human leukocyte antigen (HLA) class I molecules is largely determined by the structure of the peptide binding groove. It is expected that the molecules having similar grooves (i.e., belonging to the same supertype) might present similar/overlapping peptides. However, the extent of promiscuity among HLA class I ligands remains controversial: while in many studies T cell responses are detected against epitopes presented by alternative molecules across HLA class I supertypes and loci, peptide elution studies report minute overlaps between the peptide repertoires of even related HLA molecules. To get more insight into the promiscuous peptide binding by HLA molecules, we analyzed the HLA peptide binding data from the large epitope repository, Immune Epitope Database (IEDB), and further performed in silico analysis to estimate the promiscuity at the population level. Both analyses suggest that an unexpectedly large fraction of HLA ligands (> 50%) bind two or more HLA molecules, often across supertype or even loci. These results suggest that different HLA class I molecules can nevertheless present largely overlapping peptide sets, and that "functional" HLA polymorphism on individual and population level is probably much lower than previously anticipated. FAU - Rao, Xiangyu AU - Rao X AD - Theoretical Biology and Bioinformatics, Utrecht University, Padualaan 8, 3584CH Utrecht, The Netherlands. FAU - Hoof, Ilka AU - Hoof I FAU - Costa, Ana Isabel C A Fontaine AU - Costa AI FAU - van Baarle, Debbie AU - van Baarle D FAU - Kesmir, Can AU - Kesmir C LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110622 PL - United States TA - Immunogenetics JT - Immunogenetics JID - 0420404 RN - 0 (Epitopes, T-Lymphocyte) RN - 0 (HLA Antigens) RN - 0 (Peptides) SB - IM MH - Alleles MH - Antigen Presentation/*immunology MH - Databases, Protein MH - Epitopes, T-Lymphocyte/chemistry/genetics/*immunology MH - HLA Antigens/chemistry/genetics/*immunology MH - Humans MH - Peptides/chemistry/immunology MH - Protein Binding/immunology PMC - PMC3190086 EDAT- 2011/06/23 06:00 MHDA- 2011/12/13 00:00 PMCR- 2011/06/22 CRDT- 2011/06/23 06:00 PHST- 2011/03/31 00:00 [received] PHST- 2011/06/10 00:00 [accepted] PHST- 2011/06/23 06:00 [entrez] PHST- 2011/06/23 06:00 [pubmed] PHST- 2011/12/13 00:00 [medline] PHST- 2011/06/22 00:00 [pmc-release] AID - 552 [pii] AID - 10.1007/s00251-011-0552-6 [doi] PST - ppublish SO - Immunogenetics. 2011 Nov;63(11):691-701. doi: 10.1007/s00251-011-0552-6. Epub 2011 Jun 22.